Episode summary
Musk Turns to Tesla and SpaceX to Fuel AI Ambitions | Bloomberg Intelligence
Bloomberg Intelligence
· · Hosts: Paul Sweeney, Lisa Mateo · Guests: Craig Trudell, Jennifer Bartashus, Sam Fazeli
Summary
Tesla shareholders are being asked to weigh a possible investment in xAI, and the discussion framed it as another sign that Elon Musk’s business empire is getting more intertwined. The guest said Musk has been trying to position Tesla as more than a car company, but the move also reflects a shareholder base that may want exposure to xAI’s rapid valuation gains. He noted that Musk does not support a full merger, even as Tesla and SpaceX increasingly overlap around AI ambitions.
The conversation then shifted to Kraft Heinz, where the guest said the company appears to be preparing a breakup that would separate higher-growth sauces and seasonings from slower grocery brands. She argued the logic resembles other recent packaged-food restructurings: growth businesses are being isolated from legacy assets that have struggled to gain traction with younger shoppers and against private label competition. Berkshire Hathaway, still the largest shareholder, was described as likely open to the move.
On biotech, the guest said Novo Nordisk’s Wegovy prescription trend looks flat while Lilly’s Zepbound continues to gain share. He also pointed to patent protection that could keep Wegovy in the market much longer than some investors expect, while warning that pharma remains clouded by tariff and pricing uncertainty.
Key takeaways
- Craig Trudell said Tesla investing in xAI would show how tightly Musk’s companies are becoming intertwined.
- Trudell said some Tesla holders may want in on xAI after SpaceX reportedly put $2 billion into the startup.
- Jennifer Bartashus said Kraft Heinz’s likely breakup would separate sauces and seasonings from slower grocery brands that have not revived sales.
- Bartashus said private label has kept growing and has become a stronger competitor to legacy branded packaged foods.
- Sam Fazeli said Wegovy scripts have been flat this year while Lilly’s Zepbound continues to rise.
- Fazeli said pharma stocks remain pressured by tariff and drug-pricing uncertainty, even as M&A activity stays active.
Notable quotes
“Elon's business empire is is becoming all the more intertwined”
“Private label has been consistently growing and got a huge bump since the pandemic”
“we're still waiting to see whether the prescription counts for Nova Nordisk's US um Wiggoi numbers are up or not”
How the episode opens
Bloomberg Audio Studios podcasts radio news. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern — On Apple CarPlay and Android Auto with the Bloomberg Business App.
Listen on demand wherever you get your podcasts or watch us live on YouTube. Tesla shares, they are higher this morning. They're up about 310 of a percent, but there were some news.
Elon Musk said the company plans to poll Tesla shareholders on whether to invest in his other company, that's X AI. So, here to break it all down for us is Craig Trudell. He's Bloomberg global auto uh editor.
Uh Craig, I have to ask you, you know, this is something that came out. I mean, what kind of message is this sending?
It's it's sending that uh you know, Elon's uh Elon's business empire is is becoming all the more intertwined. So this has been uh you know sort of a a case on and off uh for for years. we can think back to uh say you know the Tesla solar city uh acquisition um you know and that's going back quite a ways but uh you know in in this case it would be uh Tesla uh you know his most valuable company in investing in in sort of his upandcomer and one where he's you know spent an awful lot of of time and and energy focused on lately as uh Tesla's electric vehicle sales have been slowing he's been really sort of dead set on on taking on open open AI and and sort of standing up a competitor to chat GPT and as with all the companies in the space spending an awful lot of money to to try and compete in in in that realm.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- ai ambitions
- tesla shareholders
- spacex investment
- kraft heinz breakup
- biotech fda wegovy
Companies and tickers mentioned
- TSLA
- KHC
- VTRS
- Tesla
- xAI
- SpaceX
- Kraft Heinz
- Mylan
Watch the episode
Watch “Musk Turns to Tesla and SpaceX to Fuel AI Ambitions | Bloomberg Intelligence” on YouTube
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Intelligence
-
Anthropic’s IPO Is Said to Be About Six Times Oversubscribed | Bloomberg Intelligence -
Instant Reaction: Nvidia CEO Jensen Huang Ousted by Nvidia Board | Bloomberg Intelligence -
Nvidia’s Huang Ousted by Board in Move That Roils AI Economy | Bloomberg Intelligence -
CoreWeave Shares Soar After AI Computing Firm Eases Debt Fears | Bloomberg Intelligence -
Anthropic Targets $1.4 Trillion Valuation in Blockbuster IPO | Bloomberg Intelligence -
Nvidia Probe Into CEO Affair Raises Thorny Questions for AI | Bloomberg Intelligence
Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
